<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002181'>Brain edema</z:hpo> that forms during the early stages of <z:hpo ids='HP_0001297'>stroke</z:hpo> involves increased transport of <z:chebi fb="1" ids="29101">Na+</z:chebi> and <z:chebi fb="193" ids="17996">Cl-</z:chebi> across an intact blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>Our previous studies have shown that a <z:chebi fb="2" ids="8069">luminal</z:chebi> <z:chebi fb="2" ids="33602">BBB</z:chebi> <z:chebi fb="1" ids="29101">Na+</z:chebi>-K+-<z:chebi fb="193" ids="17996">Cl-</z:chebi> cotransporter is stimulated by conditions present during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and that inhibition of the cotransporter by intravenous bumetanide greatly reduces <z:hpo ids='HP_0000969'>edema</z:hpo> formation in the rat middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The present study focused on investigating the effects of <z:mp ids='MP_0005039'>hypoxia</z:mp>, which develops rapidly in the brain during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, on the activity and expression of the <z:chebi fb="2" ids="33602">BBB</z:chebi> <z:chebi fb="1" ids="29101">Na+</z:chebi>-K+-<z:chebi fb="193" ids="17996">Cl-</z:chebi> cotransporter, as well as on <z:chebi fb="1" ids="29101">Na+</z:chebi>-K+-ATPase activity, cell ATP content, and intracellular volume </plain></SENT>
<SENT sid="3" pm="."><plain>Cerebral microvascular endothelial cells (CMECs) were assessed for <z:chebi fb="1" ids="29101">Na+</z:chebi>-K+-<z:chebi fb="193" ids="17996">Cl-</z:chebi> cotransporter and <z:chebi fb="1" ids="29101">Na+</z:chebi>-K+-ATPase activities as bumetanide-sensitive and <z:chebi fb="0" ids="7805">ouabain</z:chebi>-sensitive 86Rb influxes, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>ATP content was assessed by luciferase assay and intracellular volume by [3H]-3-O-<z:chebi fb="36" ids="29309">methyl</z:chebi>-<z:chebi fb="0" ids="4167">D-glucose</z:chebi> and <z:chebi fb="0" ids="36927">[14C]</z:chebi>-<z:chebi fb="27" ids="17992">sucrose</z:chebi> equilibration </plain></SENT>
<SENT sid="5" pm="."><plain>We found that 30-min exposure of CMECs to <z:mp ids='MP_0005039'>hypoxia</z:mp> ranging from 7.5% to 0.5% O2 (vs. 19% normoxic O2) significantly increased cotransporter activity as did 7.5% or 2% O2 for up to 2 h </plain></SENT>
<SENT sid="6" pm="."><plain>This was not associated with reduction in <z:chebi fb="1" ids="29101">Na+</z:chebi>-K+-ATPase activity or ATP content </plain></SENT>
<SENT sid="7" pm="."><plain>CMEC intracellular volume increased only after 4 to 5 h of <z:mp ids='MP_0005039'>hypoxia</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="1" ids="15361">pyruvate</z:chebi> deprivation increased cotransporter activity under both normoxic and hypoxic conditions </plain></SENT>
<SENT sid="9" pm="."><plain>Finally, we found that <z:mp ids='MP_0005039'>hypoxia</z:mp> increased phosphorylation but not abundance of the cotransporter protein </plain></SENT>
<SENT sid="10" pm="."><plain>These findings support the hypothesis that <z:mp ids='MP_0005039'>hypoxia</z:mp> stimulation of the <z:chebi fb="2" ids="33602">BBB</z:chebi> <z:chebi fb="1" ids="29101">Na+</z:chebi>-K+-<z:chebi fb="193" ids="17996">Cl-</z:chebi> cotransporter contributes to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced <z:hpo ids='HP_0002181'>brain edema</z:hpo> formation </plain></SENT>
</text></document>